Detailed information for compound 435799

Basic information

Technical information
  • TDR Targets ID: 435799
  • Name: 3-chloro-N-[4-chloro-2-[(4-chlorophenyl)carba moyl]phenyl]-4-[(4-ethylpiperazin-1-yl)methyl ]thiophene-2-carboxamide
  • MW: 551.916 | Formula: C25H25Cl3N4O2S
  • H donors: 2 H acceptors: 2 LogP: 6.06 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 2
  • SMILES: CCN1CCN(CC1)Cc1csc(c1Cl)C(=O)Nc1ccc(cc1C(=O)Nc1ccc(cc1)Cl)Cl
  • InChi: 1S/C25H25Cl3N4O2S/c1-2-31-9-11-32(12-10-31)14-16-15-35-23(22(16)28)25(34)30-21-8-5-18(27)13-20(21)24(33)29-19-6-3-17(26)4-7-19/h3-8,13,15H,2,9-12,14H2,1H3,(H,29,33)(H,30,34)
  • InChiKey: URWOFVWFYVNSPO-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 3-chloro-N-[4-chloro-2-[(4-chloroanilino)-oxomethyl]phenyl]-4-[(4-ethyl-1-piperazinyl)methyl]-2-thiophenecarboxamide
  • 3-chloro-N-[4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl]-4-[(4-ethylpiperazino)methyl]thiophene-2-carboxamide
  • 3-chloro-N-[4-chloro-2-[[(4-chlorophenyl)amino]-oxomethyl]phenyl]-4-[(4-ethyl-1-piperazinyl)methyl]-2-thiophenecarboxamide

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens coagulation factor II (thrombin) Starlite/ChEMBL References
Homo sapiens coagulation factor X Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Toxoplasma gondii cell-cycle-associated protein kinase, putative 0.0116 0.6583 1
Plasmodium falciparum MO15-related protein kinase 0.0124 0.7152 1
Echinococcus multilocularis geminin 0.0165 1 1
Brugia malayi Calcitonin receptor-like protein seb-1 0.0048 0.1895 1
Mycobacterium ulcerans aldehyde dehydrogenase 0.0059 0.2631 0.5
Leishmania major aldehyde dehydrogenase, mitochondrial precursor 0.0059 0.2631 1
Toxoplasma gondii aldehyde dehydrogenase 0.0059 0.2631 0.3997
Mycobacterium ulcerans aldehyde dehydrogenase 0.0059 0.2631 0.5
Schistosoma mansoni aldehyde dehydrogenase 0.0059 0.2631 0.2631
Loa Loa (eye worm) pigment dispersing factor receptor c 0.0048 0.1895 1
Mycobacterium tuberculosis Probable aldehyde dehydrogenase 0.0059 0.2631 0.5
Echinococcus granulosus aldehyde dehydrogenase mitochondrial 0.0059 0.2631 0.2631
Onchocerca volvulus 0.0021 0 0.5
Plasmodium vivax cyclin dependent kinase 7 (cdk7), putative 0.0124 0.7152 1
Loa Loa (eye worm) hypothetical protein 0.0048 0.1895 1
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.0048 0.1895 1
Brugia malayi latrophilin 2 splice variant baaae 0.0033 0.0826 0.4359
Echinococcus multilocularis aldehyde dehydrogenase, mitochondrial 0.0059 0.2631 0.2631
Mycobacterium ulcerans aldehyde dehydrogenase 0.0059 0.2631 0.5
Schistosoma mansoni aldehyde dehydrogenase 0.0059 0.2631 0.2631
Schistosoma mansoni hypothetical protein 0.0165 1 1
Loa Loa (eye worm) hypothetical protein 0.0033 0.0826 0.4359
Schistosoma mansoni hypothetical protein 0.0033 0.0826 0.0826
Trypanosoma cruzi hypothetical protein, conserved 0.0021 0 0.5
Schistosoma mansoni hypothetical protein 0.0165 1 1

Activities

Activity type Activity value Assay description Source Reference
Cp (functional) = 12 uM Anticoagulant activity in human plasma assessed as concentration required to double prothrombin time ChEMBL. 17227710
Ki (binding) = 1.6 nM Binding affinity to human factor 10a after 10 mins ChEMBL. 17227710
Ki (binding) > 5000 nM Binding affinity to human thrombin after 10 mins ChEMBL. 17227710
Ki app (binding) = 1.6 nM Binding affinity to human factor 10a after 10 mins ChEMBL. 17227710
Ki app (binding) > 5000 nM Binding affinity to human thrombin after 10 mins ChEMBL. 17227710
Ki app (binding) > 5000 nM Binding affinity to bovine trypsin after 10 mins ChEMBL. 17227710

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.